Houshmandi et al. [26] found that in the RA model rats, rhIL-35 demonstrated no significant impact on inflammatory lesions and neovascularization at arthropathic lesions but exhibited a significant inhibitory effect on inflammatory lesions and neovascularization at lesions with p35 inhibitors [26]. This evidence concerns the gene IL12A and rheumatoid arthritis.